USD
$0.00
(0.00%
)At Close (As of Oct 24, 2025)
$261.51M
Market Cap
-
P/E Ratio
-0.89
EPS
$11.00
52 Week High
$3.60
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | -$11M |
| Total Revenue | $11M |
| Cost Of Revenue | $22M |
| Costof Goods And Services Sold | $22M |
| Operating Income | -$57M |
| Selling General And Administrative | $24M |
| Research And Development | $20M |
| Operating Expenses | $46M |
| Investment Income Net | - |
| Net Interest Income | $2.9M |
| Interest Income | $2.9M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $12M |
| Income Before Tax | -$54M |
| Income Tax Expense | -$358K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$54M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$57M |
| Ebitda | -$45M |
| Net Income | -$54M |
| Field | Value (USD) |
|---|---|
| Total Assets | $210M |
| Total Current Assets | $79M |
| Cash And Cash Equivalents At Carrying Value | $39M |
| Cash And Short Term Investments | $39M |
| Inventory | $1.5M |
| Current Net Receivables | $1.8M |
| Total Non Current Assets | $131M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $70M |
| Intangible Assets Excluding Goodwill | $70M |
| Goodwill | - |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | $34M |
| Other Current Assets | $2.2M |
| Other Non Current Assets | - |
| Total Liabilities | $21M |
| Total Current Liabilities | $14M |
| Current Accounts Payable | $2.2M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $3.8M |
| Total Non Current Liabilities | $6.9M |
| Capital Lease Obligations | $4.4M |
| Long Term Debt | - |
| Current Long Term Debt | $3.1M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $7.4M |
| Other Current Liabilities | $7.8M |
| Other Non Current Liabilities | $695K |
| Total Shareholder Equity | $189M |
| Treasury Stock | - |
| Retained Earnings | -$374M |
| Common Stock | $181K |
| Common Stock Shares Outstanding | $59M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$37M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $12M |
| Capital Expenditures | $2.8M |
| Change In Receivables | - |
| Change In Inventory | -$277K |
| Profit Loss | - |
| Cashflow From Investment | -$20M |
| Cashflow From Financing | $40M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$54M |
| Field | Value (USD) |
|---|---|
| Gross Profit | -$11M |
| Total Revenue | $11M |
| Cost Of Revenue | $22M |
| Costof Goods And Services Sold | $22M |
| Operating Income | -$57M |
| Selling General And Administrative | $24M |
| Research And Development | $20M |
| Operating Expenses | $46M |
| Investment Income Net | - |
| Net Interest Income | $2.9M |
| Interest Income | $2.9M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $12M |
| Income Before Tax | -$54M |
| Income Tax Expense | -$358K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$54M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$57M |
| Ebitda | -$45M |
| Net Income | -$54M |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Nano-X Imaging Ltd. (NNOX) is at the forefront of transforming the medical imaging sector with its cutting-edge digital X-ray source technology. Based in Neve Ilan, Israel, the company is dedicated to making medical imaging more affordable and accessible, thereby enhancing diagnostic capabilities across diverse healthcare settings. As a development-stage enterprise, Nano-X is positioned to disrupt conventional imaging methodologies and contribute significantly to the advancement of healthcare technology on a global scale, ultimately aiming to improve patient outcomes.